Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

Once-weekly 500 mg subcutaneous initiation is delivered by autoinjector as two 250 mg injections, allowing self- or caregiver administration at home rather than clinic-based IV starts. FDA acceptance ...

Abstract: We present an analysis and design methodology for high-sensitivity material sensors, based on the connection of a long-delay self-injection loop to an existing oscillator. The delay and ...

Abstract: In this letter, a combined technique of self-injection locking and in-loop mixing (SIL-MIX) is applied to a phase-locked loop (PLL) frequency synthesizer, which significantly reduces the ...